Market Cap 9.57B
Revenue (ttm) 1.22B
Net Income (ttm) 73.40M
EPS (ttm) N/A
PE Ratio 34.41
Forward PE 33.44
Profit Margin 6.02%
Debt to Equity Ratio 0.15
Volume 1,969,000
Avg Vol 2,378,070
Day's Range N/A - N/A
Shares Out 155.81M
Stochastic %K 77%
Beta 1.51
Analysts Strong Sell
Price Target $68.33

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology
Sector: Healthcare
Phone: 612 379 8854
Fax: 612 656 4400
Address:
614 McKinley Place N.E., Minneapolis, United States
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 4:03 PM
$TECH RSI: 32.64, MACD: 0.0440 Vol: 2.51, MA20: 61.66, MA50: 58.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:02 AM
$TECH: The current market context shows a last close at $60.75, with an RSI of 34.23 indicating oversold conditions. The 30-day moving average (MA30) is at $61.24, suggesting a bearish trend as the price is below this level. The 50-day moving average (MA50) at $58.12 further supports a downward bias, as the price is also above this MA, indicating potential resistance. Given the 60-day high of $66.96 and low of $50.13, the price is currently closer to the lower end of this range, which could provide a bounce opportunity. Suggested entry point: $59.00 (slightly above the current price to confirm momentum). Stop loss: $57.50 (to limit losses if the price continues to decline). Targets: $62.00 (first target, near the MA30) and $64.00 (second target, approaching the 60D high). This plan leverages the oversold RSI and the proximity to the low of the range for potential upside. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:09 AM
$TECH: The last close at $59.18 indicates a position below both the 30-day moving average (MA30) of $61.24 and the 50-day moving average (MA50) of $57.80, suggesting bearish momentum. The RSI at 35.51 indicates that the stock is nearing oversold conditions, which could lead to a potential reversal. However, the price is currently closer to the 60-day low of $50.13 than the high of $66.96, reinforcing a bearish outlook in the short term. Trade Plan: - Directional Bias: Bearish, but watch for potential reversal signals due to the low RSI. - Suggested Entry: Consider entering a long position if the price breaks above $60.00, indicating a possible reversal. - Stop: Set a stop loss at $57.50 to manage risk. - Targets: First target at $62.00 (near MA30), and a second target at $64.00 (near recent resistance). Monitor market conditions closely for changes. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:45 AM
$TECH: The last close at $59.18 indicates a position below both the 30-day moving average (MA30) of $61.24 and the 50-day moving average (MA50) of $57.80, suggesting bearish momentum. The RSI at 35.51 indicates that the stock is nearing oversold conditions, which could lead to a potential reversal. However, the price is currently closer to the 60-day low of $50.13 than the high of $66.96, reinforcing a bearish outlook in the short term. Trade Plan: - Directional Bias: Bearish, but watch for potential reversal signals due to the low RSI. - Suggested Entry: Consider entering a long position if the price breaks above $60.00, indicating a possible reversal. - Stop: Set a stop loss at $57.50 to manage risk. - Targets: First target at $62.00 (near MA30), and a second target at $64.00 (near recent resistance). Monitor market conditions closely for changes. https://privateprofiteers.com
0 · Reply
Jimmy3Stylz
Jimmy3Stylz Nov. 11 at 2:26 PM
$TECH congress doesn’t miss! https://x.com/pelositracker/status/1987934381005304006?s=61&t=3Qx9I7Gngmu8kjm-5F7m9Q
1 · Reply
BillionerOfKing
BillionerOfKing Nov. 11 at 1:22 PM
$TECH Current Stock Price: $57.48 Contracts to trade: $55 TECH Nov 21 2025 Call Entry: $3.24 Exit: $5.08 ROI: 57% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 6:03 PM
UBS has updated their rating for Bio-Techne ( $TECH ) to Buy with a price target of 70.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 3:47 PM
Wells Fargo has updated their rating for Bio-Techne ( $TECH ) to Overweight with a price target of 70.
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 4:11 PM
$TECH dips 7.5% after Q1 revenue miss 📉 - EPS of 42 cents matched estimates but revenue declined 1%, missing by 0.9%. - Protein Sciences revenue down 1%, and Diagnostics & Spatial Biology decreased 4% year-over-year. Full analysis here 👉 https://www.zacks.com/stock/news/2785854/tech-stock-falls-on-q1-earnings-meet-revenues-miss-margins-up?cid=sm-stocktwits-2-2785854-body-19547&ADID=SYND_STOCKTWITS_TWEET_2_2785854_BODY_19547
0 · Reply
OptionRunners
OptionRunners Nov. 5 at 3:42 PM
$TECH Buyer of the January 16th 2026 $65C/$75C/$50P bull seagulls 1,500 times for $0.60
0 · Reply
Latest News on TECH
Bio-Techne to Present at Upcoming Investor Conferences

Nov 6, 2025, 7:00 AM EST - 8 days ago

Bio-Techne to Present at Upcoming Investor Conferences


Bio-Techne Releases First Quarter Fiscal 2026 Results

Nov 5, 2025, 6:30 AM EST - 9 days ago

Bio-Techne Releases First Quarter Fiscal 2026 Results


BIO-TECHNE DECLARES DIVIDEND

Nov 5, 2025, 6:30 AM EST - 9 days ago

BIO-TECHNE DECLARES DIVIDEND


Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript

Aug 6, 2025, 12:52 PM EDT - 3 months ago

Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript


Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 6, 2025, 6:30 AM EDT - 3 months ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results


Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 4:30 PM EDT - 3 months ago

Bio-Techne Announces Exosome Diagnostics Divestiture


Bio-Techne to Present at Investor Conferences

May 29, 2025, 7:00 AM EDT - 6 months ago

Bio-Techne to Present at Investor Conferences


Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript

May 7, 2025, 10:38 AM EDT - 6 months ago

Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript


BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

May 7, 2025, 6:30 AM EDT - 6 months ago

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM


BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

May 7, 2025, 6:30 AM EDT - 6 months ago

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS


OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 14 at 4:03 PM
$TECH RSI: 32.64, MACD: 0.0440 Vol: 2.51, MA20: 61.66, MA50: 58.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:02 AM
$TECH: The current market context shows a last close at $60.75, with an RSI of 34.23 indicating oversold conditions. The 30-day moving average (MA30) is at $61.24, suggesting a bearish trend as the price is below this level. The 50-day moving average (MA50) at $58.12 further supports a downward bias, as the price is also above this MA, indicating potential resistance. Given the 60-day high of $66.96 and low of $50.13, the price is currently closer to the lower end of this range, which could provide a bounce opportunity. Suggested entry point: $59.00 (slightly above the current price to confirm momentum). Stop loss: $57.50 (to limit losses if the price continues to decline). Targets: $62.00 (first target, near the MA30) and $64.00 (second target, approaching the 60D high). This plan leverages the oversold RSI and the proximity to the low of the range for potential upside. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:09 AM
$TECH: The last close at $59.18 indicates a position below both the 30-day moving average (MA30) of $61.24 and the 50-day moving average (MA50) of $57.80, suggesting bearish momentum. The RSI at 35.51 indicates that the stock is nearing oversold conditions, which could lead to a potential reversal. However, the price is currently closer to the 60-day low of $50.13 than the high of $66.96, reinforcing a bearish outlook in the short term. Trade Plan: - Directional Bias: Bearish, but watch for potential reversal signals due to the low RSI. - Suggested Entry: Consider entering a long position if the price breaks above $60.00, indicating a possible reversal. - Stop: Set a stop loss at $57.50 to manage risk. - Targets: First target at $62.00 (near MA30), and a second target at $64.00 (near recent resistance). Monitor market conditions closely for changes. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:45 AM
$TECH: The last close at $59.18 indicates a position below both the 30-day moving average (MA30) of $61.24 and the 50-day moving average (MA50) of $57.80, suggesting bearish momentum. The RSI at 35.51 indicates that the stock is nearing oversold conditions, which could lead to a potential reversal. However, the price is currently closer to the 60-day low of $50.13 than the high of $66.96, reinforcing a bearish outlook in the short term. Trade Plan: - Directional Bias: Bearish, but watch for potential reversal signals due to the low RSI. - Suggested Entry: Consider entering a long position if the price breaks above $60.00, indicating a possible reversal. - Stop: Set a stop loss at $57.50 to manage risk. - Targets: First target at $62.00 (near MA30), and a second target at $64.00 (near recent resistance). Monitor market conditions closely for changes. https://privateprofiteers.com
0 · Reply
Jimmy3Stylz
Jimmy3Stylz Nov. 11 at 2:26 PM
$TECH congress doesn’t miss! https://x.com/pelositracker/status/1987934381005304006?s=61&t=3Qx9I7Gngmu8kjm-5F7m9Q
1 · Reply
BillionerOfKing
BillionerOfKing Nov. 11 at 1:22 PM
$TECH Current Stock Price: $57.48 Contracts to trade: $55 TECH Nov 21 2025 Call Entry: $3.24 Exit: $5.08 ROI: 57% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 6:03 PM
UBS has updated their rating for Bio-Techne ( $TECH ) to Buy with a price target of 70.
0 · Reply
JarvisFlow
JarvisFlow Nov. 6 at 3:47 PM
Wells Fargo has updated their rating for Bio-Techne ( $TECH ) to Overweight with a price target of 70.
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 4:11 PM
$TECH dips 7.5% after Q1 revenue miss 📉 - EPS of 42 cents matched estimates but revenue declined 1%, missing by 0.9%. - Protein Sciences revenue down 1%, and Diagnostics & Spatial Biology decreased 4% year-over-year. Full analysis here 👉 https://www.zacks.com/stock/news/2785854/tech-stock-falls-on-q1-earnings-meet-revenues-miss-margins-up?cid=sm-stocktwits-2-2785854-body-19547&ADID=SYND_STOCKTWITS_TWEET_2_2785854_BODY_19547
0 · Reply
OptionRunners
OptionRunners Nov. 5 at 3:42 PM
$TECH Buyer of the January 16th 2026 $65C/$75C/$50P bull seagulls 1,500 times for $0.60
0 · Reply
ZacksResearch
ZacksResearch Nov. 5 at 3:11 PM
$TECH slips after Q1 results — margins up, but revenue disappoints ⚠️ Earnings met expectations, yet a 1% revenue decline dragged shares lower even as margins improved. See the full earnings picture here 👉 https://www.zacks.com/stock/news/2785854/tech-stock-falls-on-q1-earnings-meet-revenues-miss-margins-up?cid=sm-stocktwits-2-2785854-teaser-19544&ADID=SYND_STOCKTWITS_TWEET_2_2785854_TEASER_19544
0 · Reply
Estimize
Estimize Nov. 5 at 11:01 AM
Wall St is expecting 0.45 EPS for $TECH Q2 [Reporting 02/03 BMO] http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 4 at 1:50 PM
$TECH Share Price: $61.25 Contract Selected: Apr 17, 2026 $60 Calls Buy Zone: $1.40 – $1.73 Target Zone: $2.51 – $3.06 Potential Upside: 69% ROI Time to Expiration: 163 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Rymond_Inc
Rymond_Inc Nov. 4 at 8:20 AM
Palantir crushed Q3 estimates and raised guidance, fueled by soaring AI platform demand => Government sales—its backbone—jumped 52% YoY. Shares +4% post-earnings, now up 170% YTD => Yet analysts warn of sky-high multiples—P/S near 60x: overvalued or AI leader? $PLTR $AI $EARNINGS $STOCKS $TECH $INVESTING $MARKETS $FINANCE.X $GROWTH $VALUATION $GOVERNMENTCONTRACTS $SOFTWARE $DATA $DEFENSE $WALLSTREET
0 · Reply
allen02
allen02 Nov. 3 at 1:00 PM
$TECH Bullish Engulfing Candlestick Pattern.
0 · Reply
JackDarwin
JackDarwin Nov. 1 at 11:53 AM
$TECH Bullish Engulfing Candlestick Pattern. Wait for the confirmation from the next day's candle.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 29 at 3:44 PM
$TECH RSI: 65.10, MACD: 2.3110 Vol: 2.22, MA20: 62.03, MA50: 57.02 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Rymond_Inc
Rymond_Inc Oct. 29 at 9:24 AM
Nvidia (NVDA) CEO Jensen Huang dismisses AI bubble fears: Blackwell & Rubin chips to drive $500B revenue thru 2026 => Partnerships with Uber, Palantir boost growth. Supply deals with Samsung, Hyundai strengthen supply chain => Europe wins: Stargate UK (31K GPUs w/OpenAI), France/Italy/UK sovereign AI centers, Germany AI factory =>Shares are up +3.23% (+$6.49) premarket, +49.70% YTD (+$66.74). => NVDA eyes $5T market cap amid Xi-Trump trade talks tomorrow, signaling tech dominance $NVDA $AI $TECH $SEMICONDUCTORS $BLACKWELL $RUBIN $UBER $PALANTIR $SAMSUNG $HYUNDAI $EUROPETECH $STARGATE $OPENAI $TRADETALKS $MARKETCAP
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 24 at 3:54 PM
🏛️ 🚀 $TECH up ⬆️29.69% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 23 at 2:31 PM
🏛️ 🚀 $TECH up ⬆️26.67% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 11:05 AM
$TECH Q1 earnings on deck — but can Protein Sciences strength offset Spatial Biology weakness? Steady Protein Sciences growth may help, but funding uncertainty from NIH and biotech could pressure Spatial Biology results. Full preview and key watchpoints here 👉 https://www.zacks.com/stock/news/2774904/bio-techne-q1-earnings-preview-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2774904-teaser-17212&ADID=SYND_STOCKTWITS_TWEET_2_2774904_TEASER_17212
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 5:51 PM
Enter: $TECH NOV 21 2025 $60 CALLS Buy in Price: $3.89 - $6.00 Take Profit: $6.11 Stop Bleeding: $3.42 ROI Potential: 57% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply